I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Subcutaneous rituximab in patients with diffuse large B cel..:
Dürig, Jan
;
Uhlig, Jens
;
Gerhardt, Anke
...
https://doi.org/10.1002/cam4.5160. , 2022
Link:
https://doi.org/10.1002/cam4.5160
RT Journal T1
Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale
UL https://suche.suub.uni-bremen.de/peid=base-ftunivessen:oai:duepublico2.uni-due.de:duepublico_mods_00078921&Exemplar=1&LAN=DE A1 Dürig, Jan A1 Uhlig, Jens A1 Gerhardt, Anke A1 Ritter, Markus A1 Hapke, Gunnar A1 Heßling, Jörg A1 Staib, Peter A1 Wolff, Frieder A1 Krumm, Katja A1 Fischer von Weikersthal, Ludwig YR 2022 K1 ScholarlyArticle K1 ddc:610 K1 Medizinische Fakultät » Universitätsklinikum Essen » Klinik für Hämatologie und Stammzelltransplantation K1 complete response -- diffuse large B cell lymphoma (DLBCL) -- follicular lymphoma -- non- interventional study -- progression- free survival -- subcutaneous rituximab JF https://doi.org/10.1002/cam4.5160 LK http://dx.doi.org/https://doi.org/10.1002/cam4.5160 DO https://doi.org/10.1002/cam4.5160 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)